Pharmacokinetics of verapamil in patients with renal failure. 1985

J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn

The pharmacokinetics of verapamil was studied in patients with end-stage chronic renal failure and in normal subjects after i.v. injection of 3 mg and a single oral dose of 80 mg. Plasma levels of verapamil and its active metabolite norverapamil were measured by HPLC. After i.v. injection, the terminal phase half-life and total plasma clearance of verapamil in both groups were similar. Haemodialysis did not change the time course of plasma verapamil levels after i.v. administration. After a single oral dose, the plasma levels of verapamil and norverapamil in both groups of subjects were similar. Subsequently, normal volunteers and patients with renal failure were treated for 5 days with oral verapamil 80 mg t.d.s. There was no difference between the 2 groups of subjects in the trough and peak levels of verapamil or of norverapamil. Intravenous and oral administration of the calcium channel blocking agent had similar effects on blood pressure, heart rate and the PR-interval in the electrocardiogram in both groups. The study demonstrated that the disposition of verapamil was similar in normal subjects and in patients with renal failure.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn
January 1984, Clinical nephrology,
J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn
January 1991, Journal of clinical pharmacology,
J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn
June 1990, British journal of clinical pharmacology,
J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn
February 1978, IMJ. Illinois medical journal,
J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn
February 1977, Antimicrobial agents and chemotherapy,
J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn
April 1986, Journal of clinical pharmacology,
J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn
July 1977, Antimicrobial agents and chemotherapy,
J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn
December 1983, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn
September 1978, The Journal of antimicrobial chemotherapy,
J Mooy, and M Schols, and M v Baak, and M v Hooff, and A Muytjens, and K H Rahn
October 1979, British journal of anaesthesia,
Copied contents to your clipboard!